CYP2B7P

Across TCGA pan-cancer cohorts, CYP2B7P Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CYP2B7P data layer compared with 23 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CYP2B7P Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CYP2B7P expression acts as an unfavorable survival marker.

KIRP and LUAD are the cancer types where CYP2B7P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.040	0.912	<.001	36	view →
LUAD	OS	Median	All	0.228	0.812	.001	24	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CYP2B7P–KIRP (DFS)

Open the KIRP breakdown →